🇰🇷 Samsung Biologics

30-day score trend

📊 Quant score trend

Last 30d quant score (PER/PBR/ROE/debt/margin/growth sector percentile)

PER 41.5 / PBR 8.30 / ROE 19.4% / 부채비율 48% / 이익률 45.4% / 매출성장 +30.3% / 이익성장 +64.7%

Not a buy or sell signal. Informational only.

📊 Latest earnings — 2026-06-30

Informational — not a buy signal. Source: DART

🕸️ Metrics radar

Informational — 5 axes are 0-100 percentile, compared to sector average

Market regime — 🇰🇷 KR (Korea)

SIDE "이번 주 -0.6%. 큰 움직임 없이 어깨를 한 번 으쓱한 정도였어요."

📈 7-day price

📋 Recent filings (DART)

• 08-31 타법인주식및출자증권취득결정(종속회사의주요경영사항)
• 08-31 대규모기업집단현황공시[분기별공시(개별회사용)]
• 08-28 기업설명회(IR)개최(안내공시)

Source: DART (Korean electronic disclosure). Reference only.

📰 Recent news

• 코스피, 美·이란 충돌 재점화에 약세…6780선서 낙폭 축소

  09-01 · Naver

• 알테오젠·펩트론 등 코스닥 바이오주 '장중 뚝'...변수는?

  09-01 · Naver

• 장기공급 계약에 D램까지 품귀…메모리 가격 연쇄 급등

  09-01 · Naver

Source: Naver. Not Tradory's opinion.

🔎 Compare info

Click a button to see database-backed metrics. Informational only, not buy or sell signals.

ⓘ This compares public financial and market data. Not a buy or sell opinion.